Latest News

In Summer 2021 TransQST was delighted to announce the partnership between the project partner OcellO B.V. and Crown Bioscience (CrownBio) (link). Once completed the acquisition process for a universal takeover of rights and obligations, we now warmly welcome CrownBio as a full partner of the consortium starting in February 2022. They continue their activities in […]

The work of TransQST members was showcased at the Research Integrity Annual Lecture of the ISMIB (University of Liverpool) on 16th of December by Rahuman Sheriff, BioModels Project Leader at EMBL-EBI. The talk “Reproducibility in Systems Biology Modelling – BioModels’ Role” given at the event is based on a recent article led by the EMBL-EBI […]

The TransQST Consortium held its bi-annual General Assembly as a virtual meeting on the 15th and 16th of November. The aim of the meeting was to report on the progress of the project, to exchange ideas and discuss upcoming plans, strategies, and activities. After a 6-month no-cost extension requested to the IMI, the project will […]

We are happy to announce the recent acquisition of the TransQST partner OcellO by Crown Bioscience (CrownBio), a JSR Life Sciences global drug discovery and development service company, providing translational platforms to advance oncology, immuno-oncology, and inflammatory disorders. With this acquisition, which will contribute to make both companies stronger and more competitive, CrownBio will officially become […]

The bi-annual TransQST General Assembly Meeting was hosted in a virtual format for the 3rd time on 12th and 13th of April 2021. The first day of the meeting was dedicated to showcasing how the project has impacted the field of toxicology by improving the understanding of the safety of medicines from different perspectives. Use […]